Form 4 for BMY Bristol Myers Squibb
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0000014272-22-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-16 | 2022-03-14 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | S - Sale | $69.20 | -29.5K | 42.0K | -41% | -$2.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2022-03-14 | S | D | 29,532 | $69.20 | 41,966 | D | — | — | (F1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.18 to $69.225, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |